Novellia Raises $18M to Fix the $50B Data Problem Sitting at the Heart of Drug Development
Every major pharmaceutical company relies on real-world data to develop treatments, but most of that data comes from claims brokers and hospital systems that have never spoken to a single patient. Novellia is built on a different premise: that patients, given the right free tool and a clear ask, will consent to contribute their own complete health history to the research that could help people like them. Read the full interview to find out how this NYC startup has already landed seven-figure contracts with some of the world’s largest drugmakers, and why the founders think the highest-quality healthcare dataset in the industry is also the only one built with patients in the room.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed